Author:
Maeda Eri,Jwa Seung Chik,Kumazawa Yukiyo,Saito Kazuki,Iba Arisa,Yanagisawa‑Sugita Ayako,Kuwahara Akira,Saito Hidekazu,Terada Yukihiro,Fukuda Takashi,Ishihara Osamu,Kobayashi Yasuki
Abstract
Abstract
Background
Economic disparities affect access to assisted reproductive technology (ART) treatment in many countries. At the time of this survey, Japan provided partial reimbursement for ART treatment only for those in low- or middle-income classes due to limited governmental budgets. However, the optimal level of financial support by income class remains unclear.
Methods
We conducted a conjoint analysis of ART in Japan in January 2020. We recruited 824 women with fertility problems aged 25 to 44 years via an online social research panel. They completed a questionnaire of 16 hypothetical scenarios measuring six relevant ART attributes (i.e., out-of-pocket payment, pregnancy rate, risk of adverse effects, number of visits to outpatient clinics, consultation hours and kindness of staff) and their relations to treatment choice.
Results
Mixed-effect logistic regression models showed that all six attributes significantly influenced treatment preferences, with participants valuing out-of-pocket payment the most, followed by pregnancy rates and kindness of staff. Significant interactions occurred between high household income (≥ 8 million JPY) and high out-of-pocket payment (≥ 500,000 JPY). However, the average marginal probability of the highest-income patients (i.e., ≥ 10 million JPY, ineligible for the subsidy) receiving ART treatment at the average cost of 400,000 JPY was 47%, compared to 56 − 61% of other income participants, who opted to receive ART at an average cost of 100,000 JPY after a 300,000 JPY subsidy.
Conclusion
Our results suggest that out-of-pocket payment is the primary determinant in patients’ decision to opt for ART treatment. High-income patients were more likely to choose treatment, even at a high cost, but their income-based ineligibility for government financial support might discourage some from receiving treatment.
Funder
Health and Labour Sciences Research Grant
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Organisation for Economic Co-operation and Development (OECD). OECD Family Database, Indicator SF2.3, “Age of mothers at childbirth and age-specific fertility”, 2017. https://www.oecd.org/els/soc/SF_2_3_Age_mothers_childbirth.pdf Accessed 18 Jun 2021
2. Mills M, Rindfuss RR, McDonald P, te Velde E. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod. 2011;17:848–60.
3. de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, Dyer S, Kupka M, Adamson GD. International committee for monitoring assisted reproductive technologies world report: assisted reproductive technology 2012. Hum Reprod. 2020;35:1900–13.
4. Chambers GM, Hoang VP, Illingworth PJ. Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs. Hum Reprod. 2013;28:3111–7.
5. Chambers GM, Hoang VP, Sullivan EA, Chapman MG, Ishihara O, Zegers-Hochschild F, Nygren KG, Adamson GD. The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: an international analysis. Fertil Steril. 2014;101:191–8.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献